Mimedx (MDXG) Operating Expenses (2011 - 2026)
Mimedx (MDXG) posted Operating Expenses of $62.6 million for Q2 2026, up 9.04% sequentially from $57.4 million in Q1 2026, and down 7.26% YoY from $67.5 million in Q2 2025.
Mimedx (MDXG) Operating Expenses (2011 - 2026) Analysis & Trends
Mimedx has reported Operating Expenses for 16 years, with the latest figure at $62.6 million in Q2 2026.
- Quarterly Operating Expenses fell 7.26% year-over-year to $62.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $270.5 million (up 7.41% YoY) and the FY2025 annual result came in at $281.3 million, up 18.47% from the prior year.
- Operating Expenses advanced to $62.6 million in Q2 2026 per MDXG's latest filing, from $57.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $77.8 million in Q4 2025 and troughed at $45.1 million in Q4 2022.
- A 5-year average of $60.4 million and a median of $58.6 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses climbed 28.83% in 2025, then decreased 9.36% in 2026.
- Over 5 years, Operating Expenses stood at $45.1 million in 2022, then gained by 25.89% to $56.8 million in 2023, then increased by 13.79% to $64.6 million in 2024, then climbed by 20.46% to $77.8 million in 2025, then retreated by 19.63% to $62.6 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $62.6 million, $57.4 million, and $77.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn | 62.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.56 Mn |
| Mar 31, 2026 | 57.37 Mn |
| Dec 31, 2025 | 77.83 Mn |
| Sep 30, 2025 | 72.70 Mn |
| Jun 30, 2025 | 67.45 Mn |
| Mar 31, 2025 | 63.30 Mn |
| Dec 31, 2024 | 64.61 Mn |
| Sep 30, 2024 | 56.43 Mn |
| Jun 30, 2024 | 58.41 Mn |
| Mar 31, 2024 | 57.97 Mn |
| Dec 31, 2023 | 56.78 Mn |
| Sep 30, 2023 | 55.85 Mn |
| Jun 30, 2023 | 58.88 Mn |
| Mar 31, 2023 | 55.73 Mn |
| Dec 31, 2022 | 45.11 Mn |
| Sep 30, 2022 | 59.43 Mn |
| Jun 30, 2022 | 61.31 Mn |
| Mar 31, 2022 | 55.53 Mn |
| Dec 31, 2021 | 46.72 Mn |
| Sep 30, 2021 | 50.66 Mn |